Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-13

Clinical Trial Update: Effects of Glutamine on GLP-1 and Insulin Secretion in Man [NA]

View source ↗

Summary

A completed clinical trial investigating how glutamine affects GLP-1 and insulin secretion in individuals with Type 2 diabetes; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glutamine (glutamine)

Snippet

Sponsor: Garvan Institute of Medical Research | Conditions: Type 2 Diabetes | NA | Status: COMPLETED | Results posted: 2019-05-13